mmv665852 has been researched along with 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biswal, BK; Cherney, MM; Garen, C; Garen, G; Hammock, BD; James, MN; Morisseau, C; Niu, C | 1 |
| Grzegorzewicz, AE; Hess, TN; Jackson, M; Jones, V; Kasagami, T; Kim, IH; Lee, RE; Lenaerts, AJ; McNeil, MR; Merzlikin, O; Morisseau, C; North, EJ; Scherman, MS | 1 |
2 other study(ies) available for mmv665852 and 4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid
| Article | Year |
|---|---|
The molecular structure of epoxide hydrolase B from Mycobacterium tuberculosis and its complex with a urea-based inhibitor.
Topics: Amino Acid Sequence; Binding Sites; Epoxide Hydrolases; Humans; Hydrolysis; Kinetics; Models, Molecular; Molecular Sequence Data; Mycobacterium tuberculosis; Protein Structure, Secondary; Recombinant Proteins; Sequence Alignment; Solubility; Static Electricity; Substrate Specificity; Urea | 2008 |
Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability.
Topics: Adamantane; Animals; Antitubercular Agents; Biological Availability; Drug Evaluation, Preclinical; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Urea | 2012 |